132 related articles for article (PubMed ID: 9490065)
21. [O-methyl 14C]naproxen O-demethylase activity in human liver microsomes: evidence for the involvement of cytochrome P4501A2 and P4502C9/10.
Rodrigues AD; Kukulka MJ; Roberts EM; Ouellet D; Rodgers TR
Drug Metab Dispos; 1996 Jan; 24(1):126-36. PubMed ID: 8825200
[TBL] [Abstract][Full Text] [Related]
22. Identification of cytochrome P-450 isoform(s) responsible for the metabolism of pimobendan in human liver microsomes.
Kuriya Si; Ohmori S; Hino M; Ishii I; Nakamura H; Senda C; Igarashi T; Kiuchi M; Kitada M
Drug Metab Dispos; 2000 Jan; 28(1):73-8. PubMed ID: 10611143
[TBL] [Abstract][Full Text] [Related]
23. A predominate role of CYP1A2 for the metabolism of nabumetone to the active metabolite, 6-methoxy-2-naphthylacetic acid, in human liver microsomes.
Turpeinen M; Hofmann U; Klein K; Mürdter T; Schwab M; Zanger UM
Drug Metab Dispos; 2009 May; 37(5):1017-24. PubMed ID: 19204080
[TBL] [Abstract][Full Text] [Related]
24. The relative contribution of human cytochrome P450 isoforms to the four caffeine oxidation pathways: an in vitro comparative study with cDNA-expressed P450s including CYP2C isoforms.
Kot M; Daniel WA
Biochem Pharmacol; 2008 Aug; 76(4):543-51. PubMed ID: 18619574
[TBL] [Abstract][Full Text] [Related]
25. Constitutive and inducible levels of CYP1A1 and CYP1A2 in rat cerebral cortex and cerebellum.
Iba MM; Storch A; Ghosal A; Bennett S; Reuhl KR; Lowndes HE
Arch Toxicol; 2003 Oct; 77(10):547-54. PubMed ID: 14574441
[TBL] [Abstract][Full Text] [Related]
26. Age-related changes in hepatic expression and activity of cytochrome P450 in male rats.
Yun KU; Oh SJ; Oh JM; Kang KW; Myung CS; Song GY; Kim BH; Kim SK
Arch Toxicol; 2010 Dec; 84(12):939-46. PubMed ID: 20130842
[TBL] [Abstract][Full Text] [Related]
27. Modulation of rat liver cytochrome P450 by protein restriction assessed by biochemical and bacterial mutagenicity methods [corrected].
Cancino-Badías L; Reyes RE; Nosti R; Pérez I; Dorado V; Caballero S; Soria A; Camacho-Carranza R; Escobar D; Espinosa-Aguirre JJ
Mutagenesis; 2003 Jan; 18(1):95-100. PubMed ID: 12473742
[TBL] [Abstract][Full Text] [Related]
28. Characterization of the dose-response of CYP1B1, CYP1A1, and CYP1A2 in the liver of female Sprague-Dawley rats following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Walker NJ; Portier CJ; Lax SF; Crofts FG; Li Y; Lucier GW; Sutter TR
Toxicol Appl Pharmacol; 1999 Feb; 154(3):279-86. PubMed ID: 9931287
[TBL] [Abstract][Full Text] [Related]
29. Developmental expression of CYP2C and CYP2C-dependent activities in the human liver: in-vivo/in-vitro correlation and inducibility.
Treluyer JM; Gueret G; Cheron G; Sonnier M; Cresteil T
Pharmacogenetics; 1997 Dec; 7(6):441-52. PubMed ID: 9429229
[TBL] [Abstract][Full Text] [Related]
30. Caffeine induces cytochrome P4501A2: induction of CYP1A2 by tea in rats.
Chen L; Bondoc FY; Lee MJ; Hussin AH; Thomas PE; Yang CS
Drug Metab Dispos; 1996 May; 24(5):529-33. PubMed ID: 8723732
[TBL] [Abstract][Full Text] [Related]
31. Developmental changes in the expression of enterocytic and hepatic cytochromes P4501A in rat.
Johnson TN; Tanner MS; Tucker GT
Xenobiotica; 2002 Jul; 32(7):595-604. PubMed ID: 12162855
[TBL] [Abstract][Full Text] [Related]
32. Regulation of CYP1A and CYP3A mRNAs by ascorbic acid in guinea pigs.
Mori T; Itoh S; Ohgiya S; Ishizaki K; Kamataki T
Arch Biochem Biophys; 1997 Dec; 348(2):268-77. PubMed ID: 9434738
[TBL] [Abstract][Full Text] [Related]
33. 3-aminobenzanthrone, a human metabolite of the environmental pollutant 3-nitrobenzanthrone, forms DNA adducts after metabolic activation by human and rat liver microsomes: evidence for activation by cytochrome P450 1A1 and P450 1A2.
Arlt VM; Hewer A; Sorg BL; Schmeiser HH; Phillips DH; Stiborova M
Chem Res Toxicol; 2004 Aug; 17(8):1092-101. PubMed ID: 15310241
[TBL] [Abstract][Full Text] [Related]
34. The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine.
Eiermann B; Engel G; Johansson I; Zanger UM; Bertilsson L
Br J Clin Pharmacol; 1997 Nov; 44(5):439-46. PubMed ID: 9384460
[TBL] [Abstract][Full Text] [Related]
35. The immature rat as a potential model for chemical risks to children: Ontogeny of selected hepatic P450s.
McPhail BT; White CA; Cummings BS; Muralidhara S; Wilson JT; Bruckner JV
Chem Biol Interact; 2016 Aug; 256():167-77. PubMed ID: 27387539
[TBL] [Abstract][Full Text] [Related]
36. Sequencing and characterization of mixed function monooxygenase genes CYP1A1 and CYP1A2 of Mink (Mustela vison) to facilitate study of dioxin-like compounds.
Zhang X; Moore JN; Newsted JL; Hecker M; Zwiernik MJ; Jones PD; Bursian SJ; Giesy JP
Toxicol Appl Pharmacol; 2009 Feb; 234(3):306-13. PubMed ID: 19041884
[TBL] [Abstract][Full Text] [Related]
37. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
Butler AM; Murray M
J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
[TBL] [Abstract][Full Text] [Related]
38. Cytochrome P450 1A-dependent activities in deer, cattle and horses.
Darwish WS; Ikenaka Y; Eldaly EA; Ohno M; Sakamoto KQ; Fujita S; Ishizuka M
J Vet Med Sci; 2010 May; 72(5):561-6. PubMed ID: 20068271
[TBL] [Abstract][Full Text] [Related]
39. Differential inhibition and inactivation of human CYP1 enzymes by trans-resveratrol: evidence for mechanism-based inactivation of CYP1A2.
Chang TK; Chen J; Lee WB
J Pharmacol Exp Ther; 2001 Dec; 299(3):874-82. PubMed ID: 11714871
[TBL] [Abstract][Full Text] [Related]
40. Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
Sadrieh N; Snyderwine EG
Carcinogenesis; 1995 Jul; 16(7):1549-55. PubMed ID: 7614688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
